Cliquez pour voir le graph
			
				
				Connexions
			
		Cliquez pour voir la ligne de temps
			
				
				Ligne de temps
			
		Projets
Anciennes Équipes
Publications
Télécharger- 
													
	2025Design, synthesis, biophysical and biological evaluation of original condensed pyrrolopyrimidine and pyrrolopyridine ligands as anti-SARS-CoV-2 agents targeting G4, European Journal of Medicinal Chemistry, 2025, 292, pp.117655. ⟨10.1016/j.ejmech.2025.117655⟩.
- 
													
	2023Novel Antiviral Molecules against Ebola Virus Infection., Int J Mol Sci 2023 Sep; 24(19): .
- 
													
	2023Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands., Molecules 2023 Jan; 28(3): .
- 
													
	2022Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism., Cell Rep 2022 Oct; 41(2): 111472.
- 
													
	2021SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction., Nucleic Acids Res 2021 Jul; 49(13): 7695-7712.
- 
													
	2021Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance., Nat Commun 2021 05; 12(1): 3025.
- 
													
	2021High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris., Eur J Immunol 2021 01; 51(1): 180-190.
- 
													
	2019First-in-class allosteric inhibitors of bacterial IMPDHs, Eur J Med Chem 2019 Feb;167:124-132.
- 
													
	2018A Novel Polyaminocarboxylate Compound To Treat Murine Pulmonary Aspergillosis by Interfering with Zinc Metabolism, Antimicrob. Agents Chemother. 2018 Jun;62(6).
- 
													
	2017Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT, Sci Rep. 2017 Nov 23;7(1):16129.
- 
												
													+Voir la liste complète de publications

 
																	


